IRIDEX 

$1.1750
10
-$0.00-0.42% 今天

統計

當日最高
1.18
當日最低
1.174
52週高點
1.65
52週低點
0.87
成交量
24,762
平均成交量
-
市值
20.2M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

6Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
-0.12
-0.08
-0.05
-0.01
預期EPS
-0.01
實際EPS
不適用

財務

-18.31%利潤率
未盈利
2019
2020
2021
2022
2023
2024
97.34M營收
-17.82M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 IRIX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
Show more...
執行長
Mr. Scott A. Shuda J.D.
員工
93
國家
美國
ISIN
US4626841013

上市

0 Comments

分享你的想法

FAQ

IRIDEX 今天的股價是多少?
IRIX 目前價格為 $1.18 USD,過去 24 小時下跌了 -0.42%。在圖表上更密切關注 IRIDEX 股票的表現。
IRIDEX 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,IRIDEX 的股票以代號 IRIX 進行交易。
IRIDEX 的股價在上漲嗎?
IRIX 股票較上週上漲 +4.91%,本月上漲 +16.34%,過去一年 IRIDEX 上漲 +19.29%。
IRIDEX 的市值是多少?
今天 IRIDEX 的市值為 20.2M
IRIDEX 下一次財報日期是什麼時候?
IRIDEX 將於 August 06, 2026 公布下一次財報。
IRIDEX 上一季度的財報如何?
IRIX 上一季度的財報為每股 -0.03 USD,預估為 -0.07 USD,帶來 +57.14% 的驚喜。下一季度的預估財報為每股 不適用 USD。
IRIDEX 去年的營收是多少?
IRIDEX 去年的營收為 97.34MUSD。
IRIDEX 去年的淨利是多少?
IRIX 去年的淨收益為 -17.82MUSD。
IRIDEX 有多少名員工?
截至 June 16, 2026,公司共有 93 名員工。
IRIDEX 位於哪個產業?
IRIDEX從事於Health & Wellness產業。
IRIDEX 何時完成拆股?
IRIDEX 最近沒有進行任何拆股。
IRIDEX 的總部在哪裡?
IRIDEX 的總部位於 美國 的 Mountain View。